Clinical Trials · NCT06109649
A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- Clinuvel, Inc.
- Enrollment
- 200
- Start date
- Oct 2023
- Locations
- 30 sites, 4 countries
- Primary endpoint
- Percentage of patients achieving T-VASI 50 on the body